- Home
- MQ vs HRMY Comparison
MQ vs HRMY Comparison
Compare MQ & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- HRMY
- Stock Information
- Founded
- MQ 2010
- HRMY 2017
- Country
- MQ United States
- HRMY United States
- Employees
- MQ N/A
- HRMY N/A
- Industry
- MQ Computer Software: Prepackaged Software
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- MQ Technology
- HRMY Health Care
- Exchange
- MQ Nasdaq
- HRMY Nasdaq
- Market Cap
- MQ 1.9B
- HRMY 1.9B
- IPO Year
- MQ 2021
- HRMY 2020
- Fundamental
- Price
- MQ $3.73
- HRMY $34.23
- Analyst Decision
- MQ Buy
- HRMY Buy
- Analyst Count
- MQ 16
- HRMY 10
- Target Price
- MQ $5.77
- HRMY $49.80
- AVG Volume (30 Days)
- MQ 5.6M
- HRMY 586.0K
- Earning Date
- MQ 11-04-2024
- HRMY 02-20-2025
- Dividend Yield
- MQ N/A
- HRMY N/A
- EPS Growth
- MQ N/A
- HRMY N/A
- EPS
- MQ 0.03
- HRMY 2.11
- Revenue
- MQ $490,027,000.00
- HRMY $681,879,000.00
- Revenue This Year
- MQ N/A
- HRMY $24.83
- Revenue Next Year
- MQ $15.52
- HRMY $18.66
- P/E Ratio
- MQ $137.79
- HRMY $16.18
- Revenue Growth
- MQ N/A
- HRMY 25.83
- 52 Week Low
- MQ $3.37
- HRMY $28.14
- 52 Week High
- MQ $7.36
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- MQ 37.31
- HRMY 50.53
- Support Level
- MQ $3.61
- HRMY $33.01
- Resistance Level
- MQ $3.86
- HRMY $35.58
- Average True Range (ATR)
- MQ 0.15
- HRMY 1.16
- MACD
- MQ 0.00
- HRMY 0.16
- Stochastic Oscillator
- MQ 12.26
- HRMY 60.54
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.